227 related articles for article (PubMed ID: 23982256)
1. Total skin-sparing mastectomy in BRCA mutation carriers.
Peled AW; Irwin CS; Hwang ES; Ewing CA; Alvarado M; Esserman LJ
Ann Surg Oncol; 2014 Jan; 21(1):37-41. PubMed ID: 23982256
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic and therapeutic mastectomy in BRCA mutation carriers: can the nipple be preserved?
Reynolds C; Davidson JA; Lindor NM; Glazebrook KN; Jakub JW; Degnim AC; Sandhu NP; Walsh MF; Hartmann LC; Boughey JC
Ann Surg Oncol; 2011 Oct; 18(11):3102-9. PubMed ID: 21947588
[TBL] [Abstract][Full Text] [Related]
3. Outcomes after total skin-sparing mastectomy and immediate reconstruction in 657 breasts.
Warren Peled A; Foster RD; Stover AC; Itakura K; Ewing CA; Alvarado M; Hwang ES; Esserman LJ
Ann Surg Oncol; 2012 Oct; 19(11):3402-9. PubMed ID: 22526909
[TBL] [Abstract][Full Text] [Related]
4. Total skin-sparing mastectomy and immediate breast reconstruction: an evolution of technique and assessment of outcomes.
Wang F; Peled AW; Garwood E; Fiscalini AS; Sbitany H; Foster RD; Alvarado M; Ewing C; Hwang ES; Esserman LJ
Ann Surg Oncol; 2014 Oct; 21(10):3223-30. PubMed ID: 25052246
[TBL] [Abstract][Full Text] [Related]
5. Tumor Involvement of the Nipple in Total Skin-Sparing Mastectomy: Strategies for Management.
Amara D; Peled AW; Wang F; Ewing CA; Alvarado M; Esserman LJ
Ann Surg Oncol; 2015 Nov; 22(12):3803-8. PubMed ID: 26023040
[TBL] [Abstract][Full Text] [Related]
6. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
[TBL] [Abstract][Full Text] [Related]
7. Expanding the Indications for Total Skin-Sparing Mastectomy: Is It Safe for Patients with Locally Advanced Disease?
Peled AW; Wang F; Foster RD; Alvarado M; Ewing CA; Sbitany H; Esserman LJ
Ann Surg Oncol; 2016 Jan; 23(1):87-91. PubMed ID: 26170194
[TBL] [Abstract][Full Text] [Related]
8. Nipple-Sparing Mastectomy and Its Application on BRCA Gene Mutation Carrier.
Co M; Chiu R; Chiu TM; Chong YC; Lau S; Lee YH; To HM; Kwong A
Clin Breast Cancer; 2017 Dec; 17(8):581-584. PubMed ID: 28428099
[TBL] [Abstract][Full Text] [Related]
9. Nipple skin-sparing mastectomy is feasible for advanced disease.
Burdge EC; Yuen J; Hardee M; Gadgil PV; Das C; Henry-Tillman R; Ochoa D; Korourian S; Suzanne Klimberg V
Ann Surg Oncol; 2013 Oct; 20(10):3294-302. PubMed ID: 23975304
[TBL] [Abstract][Full Text] [Related]
10. Oncologic safety of nipple skin-sparing or total skin-sparing mastectomies with immediate reconstruction.
Boneti C; Yuen J; Santiago C; Diaz Z; Robertson Y; Korourian S; Westbrook KC; Henry-Tillman RS; Klimberg VS
J Am Coll Surg; 2011 Apr; 212(4):686-93; discussion 693-5. PubMed ID: 21463813
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer treatment in mutation carriers: surgical treatment.
Biglia N; D'Alonzo M; Sgro LG; Tomasi Cont N; Bounous V; Robba E
Minerva Ginecol; 2016 Oct; 68(5):548-56. PubMed ID: 26822896
[TBL] [Abstract][Full Text] [Related]
12. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
13. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
Adem C; Reynolds C; Soderberg CL; Slezak JM; McDonnell SK; Sebo TJ; Schaid DJ; Myers JL; Sellers TA; Hartmann LC; Jenkins RB
Cancer; 2003 Jan; 97(1):1-11. PubMed ID: 12491499
[TBL] [Abstract][Full Text] [Related]
14. Oncologic Safety of Nipple-Sparing Mastectomy for Breast Cancer in BRCA Gene Mutation Carriers: Outcomes at 70 Months Median Follow-Up.
Webster AJ; Shanno JN; Santa Cruz HS; Kelly BN; Garstka M; Henriquez A; Specht MC; Gadd MA; Verdial FC; Nguyen A; Oseni TO; Coopey SB; Smith BL
Ann Surg Oncol; 2023 Jun; 30(6):3215-3222. PubMed ID: 36604360
[TBL] [Abstract][Full Text] [Related]
15. Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study.
Jakub JW; Peled AW; Gray RJ; Greenup RA; Kiluk JV; Sacchini V; McLaughlin SA; Tchou JC; Vierkant RA; Degnim AC; Willey S
JAMA Surg; 2018 Feb; 153(2):123-129. PubMed ID: 28903167
[TBL] [Abstract][Full Text] [Related]
16. How Protective are Nipple-Sparing Prophylactic Mastectomies in BRCA1 and BRCA2 Mutation Carriers?
Garstka M; Henriquez A; Kelly BN; Webster A; Khubchandani JA; Hughes K; Nguyen A; Oseni T; Specht M; Coopey SB; Gadd MA; Smith BL
Ann Surg Oncol; 2021 Oct; 28(10):5657-5662. PubMed ID: 34296361
[TBL] [Abstract][Full Text] [Related]
17. Total skin-sparing mastectomy: complications and local recurrence rates in 2 cohorts of patients.
Garwood ER; Moore D; Ewing C; Hwang ES; Alvarado M; Foster RD; Esserman LJ
Ann Surg; 2009 Jan; 249(1):26-32. PubMed ID: 19106672
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers: very low risk for subsequent breast cancer.
Kaas R; Verhoef S; Wesseling J; Rookus MA; Oldenburg HS; Peeters MJ; Rutgers EJ
Ann Surg; 2010 Mar; 251(3):488-92. PubMed ID: 20134318
[TBL] [Abstract][Full Text] [Related]
19. Low rate of complications in nipple-sparing mastectomy for patients with
Frasson AL; Falcone AB; Barbosa F; Anton de Souza AB; Malhone C; Miranda I; Vollbrecht B; Rodriguez Martinez Frasson MA; Kobe L; Lichtenfels M
Per Med; 2023 Nov; 20(6):493-501. PubMed ID: 37909344
[No Abstract] [Full Text] [Related]
20. Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.
Kirova YM; Stoppa-Lyonnet D; Savignoni A; Sigal-Zafrani B; Fabre N; Fourquet A;
Eur J Cancer; 2005 Oct; 41(15):2304-11. PubMed ID: 16140006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
